Neuroimmune Consequences of eIF4E Phosphorylation on Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting side effect that occurs in up to 63% of patients and has no known effective treatment. A majority of studies do not effectively assess sex differences in the onset and persistence of CIPN. Here we investigated the onset of CI...

Descripción completa

Detalles Bibliográficos
Autores principales: Agalave, Nilesh M., Mody, Prapti H., Szabo-Pardi, Thomas A., Jeong, Han S., Burton, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071873/
https://www.ncbi.nlm.nih.gov/pubmed/33912169
http://dx.doi.org/10.3389/fimmu.2021.642420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071873/
https://www.ncbi.nlm.nih.gov/pubmed/33912169
http://dx.doi.org/10.3389/fimmu.2021.642420

Ejemplares similares